Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Emergent BioSolutions Inc
EBS
Healthcare
Biotechnology
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products...
, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:EBS)
New Post
View:
Posts & Comments
Threaded Posts
(6)
•••
10QKing
X
Post by
10QKing
on Sep 30, 2024 10:33am
EBS California to Require narcan be at all businesses in the
EBS California to Require narcan be at all businesses in the state singed into law mins ago This should go nationwide to help save lives
(59)
•••
Nibinator
X
Post by
Nibinator
on Aug 30, 2024 6:10am
BUY BUY BUY BUY BUY
There yoy have it fellows day traders the winner for today
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 25, 2024 11:48am
BUY BUY BUY BUY BUY
Sky rocketed since May to 600% i think it will continue to 20$ 24$
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Jun 27, 2022 8:05am
HERE’S WHY EMERGENT BIOSOLUTIONS IS WORTH INVESTING!
$EBS Emergent BioSolutions, Inc. (NYSE:EBS), a life sciences company is developing a portfolio of vaccines and therapeutics for urgent health threats, announced the acceptance of a
...more
(1)
•••
zalmonella
X
Post by
zalmonella
on Nov 03, 2021 2:37pm
EArnings tomorrow
Hmmmm... .price rising, low volume, lots of exciteability. Not sure what that means. Guess I'll hang on and find out.
(1)
•••
zalmonella
X
Post by
zalmonella
on Jul 30, 2021 2:02am
Turnaround? We'll see...
Well, the earnings call today noted they punted Sean Kirk, VP of Manufacturing after 18 years. Potentially that should ahve been done long ago, but one has to recognize EBS has been a low-cost
...more
(6)
•••
jenkinjt
X
Post by
jenkinjt
on Apr 06, 2021 5:59pm
Taking a hit for its' sloppiness
Such a shame they can't run a decent operation.. Bunch of moneygrubbing hacks!!! Should fold their tent and retire...
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >